Transforming the Management
of Dermatologic Cancers
Enabling More Accurate Treatment Plan Decisions With Our Line of Gene Expression Profile (GEP) Tests
CUTANEOUS MELANOMA
PROGNOSTIC
Predicting Individual Risk of Recurrence or Metastasis in Stage I, II and III Melanoma
DIAGNOSTIC
A Highly Accurate and Objective Test Characterizing Difficult-to-Diagnose Melanocytic Lesions
SQUAMOUS CELL
CARCINOMA
PROGNOSTIC
Better Identifies Risk of Metastasis in Patients With One or More Risk Factors
UVEAL
MELANOMA
